Scarica l'app Stockscreener
0.629
42.95%
0.189
Dopo l'orario di chiusura:
.58
-0.049
-7.79%
Tuhura Biosciences Inc Borsa (HURA) Ultime notizie
TuHURA Biosciences receives FDA orphan drug designation for melanoma drug By Investing.com - Investing.com South Africa
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma - MEXC
TuHURA Receives FDA Orphan Drug Designation - intellectia.ai
TuHURA Biosciences receives FDA orphan drug designation for melanoma drug - Investing.com
FDA grants orphan status to TuHURA melanoma therapy IFx-2.0 - stocktitan.net
Quarterly Earnings: What dividend growth rate does TuHURA Biosciences Inc offer2025 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice - TipRanks
TuHURA Biosciences Received Notice of Noncompliance - TradingView
Will TuHURA Biosciences Inc. outperform its industry peers2025 Volume Leaders & Safe Capital Investment Plans - mfd.ru
Risk Recap: How is TuHURA Biosciences Inc managing supply chain issuesJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn
Breakout Watch: How is TuHURA Biosciences Inc managing supply chain issuesWeekly Profit Summary & Weekly Setup with High ROI Potential - baoquankhu1.vn
TuHURA Biosciences (NASDAQ:HURA) Shares Up 0.5% – Here’s Why - Defense World
MACD Signal: Will TuHURA Biosciences Inc outperform its industry peers2025 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Will TuHURA Biosciences Inc. stock gain from lower inflation2025 Investor Takeaways & Expert Curated Trade Setup Alerts - Улправда
Will TuHURA Biosciences Inc. stock benefit from green energy trendsQuarterly Portfolio Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is TuHURA Biosciences Inc. stock supported by innovation pipelinePrice Action & Verified Momentum Stock Alerts - ulpravda.ru
HURA: Analyst Reiterates Buy Rating, Lowers Price Target | HURA Stock News - GuruFocus
Risk Hedge: Will TuHURA Biosciences Inc. (PL3) stock attract long term capital inflows - Улправда
Can TuHURA Biosciences Inc. (PL3) stock expand revenue streams2025 Historical Comparison & Weekly High Return Stock Forecasts - ulpravda.ru
Why TuHURA Biosciences Inc. stock is popular among millennialsTake Profit & AI Driven Stock Price Forecasts - ulpravda.ru
Why TuHURA Biosciences Inc. stock could see breakout soonMid Cap Growth Trends & Rapid Capital Gain - ulpravda.ru
TuHURA Biosciences Inc Stock Analysis and ForecastRetail Trading Trends & Enter Your Email to Get Stock Alerts - earlytimes.in
Tuhura Biosciences amends loan agreement, secures full $3M - MSN
Is TuHURA Biosciences Inc PL3 a good long term investmentStop Loss Placement Tips & Big Profit Small Investment - earlytimes.in
What the Latest News Means for ABS Marine Services Limited Stock InvestorsTake Profit Strategies & Free Tremendous Portfolio Expansion - earlytimes.in
TUHURA Biosciences announces $15.6M registered direct offering - MSN
What analysts say about TuHURA Biosciences Inc PL3 stockEvening Star Patterns & Don’t Miss These Undervalued Stocks - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Actinogen Medical (OtherATGGF) and TuHURA Biosciences (HURA) - The Globe and Mail
Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Will TuHURA Biosciences Inc. (PL3) stock attract long term capital inflows2025 Technical Patterns & Expert Verified Movement Alerts - Улправда
Volume Summary: Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Trade Ideas & Free Safe Capital Growth Stock Tips - Улправда
Can TuHURA Biosciences Inc. stock reach $100 price targetPortfolio Update Summary & High Accuracy Trade Signal Alerts - Улправда
Aug Retail: How TuHURA Biosciences Inc. stock compares to industry benchmarksWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
2026 world cup match preview insights: Will TuHURA Biosciences Inc. stock outperform Nasdaq index2026 world cup usa national team round of 32 key players transition play match prediction guide - ulpravda.ru
How TuHURA Biosciences Inc. stock compares to industry benchmarksTrade Ideas & Consistent Growth Equity Picks - Улправда
Will TuHURA Biosciences Inc. stock deliver shareholder valueTrade Volume Report & Free Expert Approved Momentum Trade Ideas - Улправда
Is TuHURA Biosciences Inc. (PL3) stock a top pick for value investors2025 Trading Recap & Stepwise Trade Signal Implementation - Улправда
Can TuHURA Biosciences Inc. stock sustain free cash flow growth2025 Stock Rankings & Weekly High Potential Stock Alerts - DonanımHaber
Can TuHURA Biosciences Inc. stock weather global recessionWeekly Loss Report & Growth Focused Stock Reports - Улправда
TuHURA Biosciences Earnings Notes - Trefis
Rate Hike: Can TuHURA Biosciences Inc. (PL3) stock expand revenue streamsCEO Change & Weekly Top Gainers Alerts - Улправда
[Form 4] TuHURA Biosciences, Inc./NV Insider Trading Activity - Stock Titan
TuHURA Biosciences, Inc. (HURA) CEO discloses 3.4M option grant terms in filing - Stock Titan
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
TuHURA Biosciences Announces Its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - 富途牛牛
TuHURA Biosciences announces release of Kintara’s CVR - TipRanks
0.23%
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):